PGAM1 and cancer: Of note, our recent studies have also revealed that PGAM1 inhibition inactivated homologous recombination repair and exhibited synthetic lethality with PARP inhibitors in cancer cells, which further inspired the interest to develop PGAM1 inhibitors for the treatment of cancer (Qu et al., 2017).